Every week, we compare the reported Afrezza pre-rebated prescription related numbers, and individual prescription sizes have been getting larger over time, due to changes in their SKUs (i.e. number and composition of cartridges per prescription).
But we never see the actual weekly Afrezza Net Sales numbers, just the subscription services' tabulated, then published pre-rebated Afrezza Gross Sales and prescription numbers, with Gross Sales presumably based on a List Price. We have to estimate the Net Sales (after all rebates), and that is just an estimate, even for the investment writers, because the reported Gross Sales dollars aren't yet rebated, and they don't include the non-rebated Afrezza Gross Sales numbers. Better than nothing, I guess, because the reported prescription numbers do indicate the short-term direction of Afrezza demand. JMHO.